Clinical Trial Update: miR-200b & miR-21 in Diabetic Wounds

View source ↗

Summary

A clinical trial studying the microRNAs miR-200b and miR-21 for diabetic wounds has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Foot Ulcer

Drugs mentioned

• miR-200b (miR-200b)
• miR-21 (miR-21)

Snippet

Sponsor: Indiana University | Conditions: Diabetes Mellitus, Foot Ulcer | Status: COMPLETED